9
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Preventing and curtailing injecting drug use: a review of opportunities for developing and delivering 'route transition interventions'

Pages 441-451 | Published online: 12 Jul 2009

  • O'Hare P, Newcombe R, Mathews A, Buning EC, Drucker E, eds. The reduction of drug-related harm. London: Routledge, 1992.
  • Heather N, Wodak A, Nadelmann EA, O'Hare P, eds. Psychoactive drugs and harm reduction: from iaith to science. London: Whurr Publishers, 1993.
  • Waller T, Holmes R. Hepatitis C: time to wake up. Druglink 1993; May/June:7-9.
  • Crofts N, Hopper JL, Scott Bowden D, Breschkin AM, Milner R, Locarnini SA. Hepatitis C infection in a cohort of Victorian injecting drug users. Med J Aust 1993;119:237-41.
  • Crofts N, Stewart T, Hearne P, Ping XY, Breschkin AM, Locarnini SA. Spread of bloodborne viruses among Australian prison entrants. Br Med J 199i;310:285-8.
  • Coutinho RA. HIV and hepatitis C among injecting drug users: success in preventing HIV has not been mirrored for hepatitis C. Br Med J 1998;317:425-6.
  • Stimson GV. Has the UK averted an epidemic of HIV- 1 among drug injectors? Addiction 1996;91:1085-8.
  • Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 1992;87:1527-36.
  • Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney Australia. Addiction 1996;91:81-7.
  • Gossop M.Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. Br Med J 1996;313:402.
  • President of the Council. Tackling drugs to build a better Britain: the government's 10 year strategy for tackling drugs misuse. London: Stationery Office, 1998.
  • United Nations Drug Control Programme. World drug report. Oxford: Oxford University Press, 1997.
  • Strang J, Des Jarlais DC, Griffiths P, Gossop M. The study of transitions in the route of drug use: the route from one route to another. Br J Addict 1992;87:473-83.
  • Griffiths P, Gossop M, Powis B, Strang J. Transitions in patterns of heroin administration. Addiction 1994;89:301-9.
  • Darke S, Cohen J, Ross J, Hando J, Hall W. Transitions between routes of administration of regular amphetamine users. Addiction 1994;89:1077-83.
  • Wodak A. Injecting nation: Achieving control of hepatitis C in Australia. Drug Alcohol Rev 1997;16:27i-84.
  • Stimson GV. Public health, injecting drug use, and the future of harm reduction: Where do we go from here? Narrowing the Divide Conference, Mainliners/The HIV Project. London: South Bank Centre, 1997.
  • Strang J, Griffiths P, Gossop M. Heroin in the U nited Kingdom: different forms, different origins, and the relationship to routes of administration. Drug Alcohol Rev 1997)16:329-37.
  • Strang J, King L. Heroin is more than just diamor- phine. Addict Res 1997;5:iii-vii.
  • Loxley W; Davidson P. Forgetting to breathe: opioid overdose and young injecting drug users in Perth. Perth: National Centre for Research into the Prevention of Drug Abuse, 1998.
  • Parker H, Bakx K, Newcombe R. Living with heroin; the impact of a drugs epidemic on an English community. Milton Keynes: Open University Press, 1988.
  • Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat 1990;7:1-10.
  • Des Jarlais DC, Casriel C, Friedman SR, Rosenblaum A. AIDS and the transition to drug injection-results of a randomized trial prevention programme. Br J Addict 1992;87:493-8.
  • Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to reduce initiation into injecting. Drugs: Educ Prev Policy 1998;5:185-94.
  • Des Jarlais DC, Friedman SR. Target groups for preventing AIDS among intravenous drug users. J Appl Soc Psychol 1987;17:251-68.
  • Shelley H; Jones K; Hunt N. Amphetamine injecting: risk, sharing and help-seeking. Maidstone: Maidstone Health Authority, 1993.
  • Dole VP, Nyswander M. A medical treatment for diacetyl morphine (heroin) addiction. JAMA 1961;193:80-4.
  • Dole VP, Nyswander M. Heroin addiction - a metabolic disease. JAMA 1967;120:19-24.
  • Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programmes, services and outcomes. New York: Springer Verlag, 1991;
  • Ward J, Mattick RP, HaIl W. Key issues in methadone maintenance treatment. Sydney: New South Wales University Press, 1992.
  • Farrell M, Ward J, Mattick R, et al. Methadone maintenance treatment in opiate dependence: a review. Br Med J 1994;309:997-1001.
  • Strang J, Finch E, Hankinson I, Farrell M, Taylor C, Gossop M. Methadone treatment for opiate addiction: benefits in the first month. Addict Res 1997;5:71-6.
  • Capelhorn JR, Bell J, Kleinbaum DG, Glebski VJ. Methadone dose and heroin use during maintenance treatment. Addiction 1993;88 :119-24.
  • Newman RG, Peyser N. Methadone treatment: experiment and experience. J Psychoactive Drugs 1991;23:115-21.
  • McLellan AT, Woody GE, Luborsky L, Goehl L. Is the counsellor an 'active ingredient' in substance abuse rehabilitation? An examination of the treatment success among four counsellors. J Nerv Ment Dis 1988;176:423-30.
  • Southwell M, Jankowska T, Hunt N. Drug transitions: an essential tool in the prevention of HCV among those in methadone maintenance programmes. Narrowing the Divide Conference, Mainliners/The HIV Project. London; South Bank Centre, 1997.
  • Fleming PM, Roberts D. Is the prescription of amphetamine justified as a harm reduction measure? J Roy Soc Health 1994;127-31.
  • Myles M. Treatment for amphetamine use in the United Kingdom. In: Klee H, ed. Amphetamine misuse: international perspectives on current trends. Amsterdam: Harwood Academic Publishers, 1997.
  • Klee H, Wright S, Rothwell J. Amphetamine use and treatment. London: Department of Health, 1998.
  • Kail K. Amphetamine abuse in Sweden. In: Klee H, ed. Amphetamine misuse: international perspectives on current trends. Amsterdam: Harwood Academic Publishers, 1997.
  • Klee H. A new target in behavioural research: amphetamine misuse. Br J Addict 1992;87:439-46.
  • Hando J, Hall W. Patterns of amphetamine use in Australia. In: Klee H, ed. Amphetamine misuse: international perspectives on current trends. Amsterdam: Harwood Academic Publishers, 1997:81-110.
  • Advisory Council on the Misuse of Drugs. AIDS and Drug Misuse Update. London: HMSO, 1993.
  • Mitcheson M, Edwards G, Hawks D, Ogbourne A. Treatment of methylamphetamine users during the 1968 epidemic. In: Edwards G, Russell MAH, Hawks D, Maccaffery M, eds. Drugs and drug dependence. London: Saxon House Publishers, 1976.
  • Farrell M, Howes S, Griffiths P, Williamson S, Taylor C. Stimulant needs assessment project. London: Department of Health, 1998;
  • Huizer H. Efficacy of volatilisation during heroin smoking. Netherlands: Ministry of Justice, 1988.
  • Strang J, Beam J, Farrell M, et al. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev 1998)17:197-211.
  • Lefebvre C. Social marketing and health promotion. In: Bun ton R, Macdonald G, eds. Health Promotion: Disciplines and Diversity. London: Routledge, 1992.
  • Marks J, Palombella A. Prescribing smokable drugs. Lancet 1991;335:864.
  • Pharmaceutical Journal. Heroin reefers - a protocol. Pharmaceutical Journal 1994;252:53-4.
  • Jankowska T, Southwell M, Picorne W. The implementation of promoting heroin chasing as a harm reduction tool. 8th International Conference on the Reduction of Drug Related Harm, Maison de la Mutualite, Paris, 1997.
  • Southwell M. 'Up your bum'--a simple, safer route of drug-taking or a squirt too far! 8th International Conference on the Reduction of Drug-Related Crime, Maison de la Mutualite, Paris, 1997.
  • Lewit EM. US tobacco taxes: behavioural effects and policy implications. Br J Addict 1989;84:1217-35.
  • Edwards G, Anderson P, Babor TF, et al. Alcohol policy and the public good. Oxford: Oxford University Press, 1994.
  • Reuter P, Kleinman MAR. Risks and prices: an economic analysis of drug law enforcement. In: Tonry M, Morris N, eds. Crime and justice: an annual review of research. Chicago: University of Chicago Press, 1986.
  • Moore M. Buy and bust: the effective regulation of an illicit market in heroin. Lexington: Lexington Books, 1977.
  • O'Neil J, Baker PB, Gough TA. Illicitly imported heroin products: some physical and chemical features indicative of their origin. J Forens Sci 1984;29:885-902.
  • Power R, Hartnoll R, Daviaud E. Drug injecting, AIDS, and risk behaviour: potential for change and intervention strategies. Br J Addict 1988;83:649-54.
  • Griffiths P, Vingoe L, Jansen K, Sherval J, Lewis R, Hartnoll R, Milson M. New trends in synthetic drugs in the European Union. Lisbon: EMCDDA, 1997.
  • Dean A. Space and substance misuse in rural communities. Int J Sociol Social Policy 1995;15:134-55.
  • Pawson R, Tilley N. Realistic evaluation. London: Sage, 1997.
  • Dorn N, Murji K. Drug prevention: a review of the English language literature. ISDD Res Monogr 1992.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.